Top Cities for Uveitis Clinical Trials
Uveitis clinical trials are recruiting across 9 cities. Here are the cities with the most active studies:
About Uveitis
Uveitis is inflammation of the middle layer of the eye (uvea) that can cause eye pain, redness, and vision changes. It can result from infections, autoimmune conditions, or be idiopathic. Treatment includes corticosteroid eye drops, immunosuppressive medications, and biologics.
Clinical trials are advancing new treatments for uveitis. Currently, 1 studies are recruiting a combined 300 participants across the United States. Research is being conducted by 1 organizations including Priovant Therapeutics, Inc..
2026 Uveitis Research Landscape
As of March 2026, the uveitis clinical trial landscape includes 1 actively recruiting studies across 9 cities in the United States. These studies are collectively seeking 300 participants, with an average enrollment target of 300 per study.
Research is being led by 1 organization, including Priovant Therapeutics, Inc..
Geographically, uveitis trials are most concentrated in Los Angeles, California (2 trials); Phoenix, Arizona (1 trial); Bakersfield, California (1 trial); Beverly Hills, California (1 trial); Fullerton, California (1 trial) and 4 other cities.
Featured Uveitis Studies
Highlighted recruiting studies for uveitis, selected by enrollment size and research scope.
A Study of Brepocitinib in Adults With Active, Non-Infectious, Non-Anterior Uveitis
The purpose of this study is to determine the safety and efficacy of brepocitinib in participants with active, non-anterior (intermediate, posterior, or pan) non-infectious uveitis (NIU).
Frequently Asked Questions About Uveitis Clinical Trials
Are there uveitis clinical trials near me?
Yes, there are 1 uveitis clinical trials currently recruiting across 9+ cities in the United States, including Los Angeles, California; Phoenix, Arizona; Bakersfield, California. Browse the studies above to find one at a location convenient for you.
How do I join a uveitis clinical trial?
To join a uveitis clinical trial: 1) Browse the available studies on this page, 2) Click on a study that interests you, 3) Check the study locations to find a site near you, 4) Review the eligibility criteria, and 5) Contact the study site or complete the eligibility form. The process is free and you can withdraw at any time.
Are uveitis clinical trials free?
Yes, participation in uveitis clinical trials is free. Study-related treatments, medical tests, and doctor visits are provided at no cost to participants. Many studies also offer compensation for your time and travel expenses.
What types of uveitis treatments are being studied?
Current uveitis clinical trials are testing a range of approaches. These include new drugs, combination therapies, medical devices, and other interventions sponsored by 1 research organizations.
Is it safe to participate in uveitis clinical trials?
Clinical trials are carefully regulated by the FDA and institutional review boards (IRBs). All trials must follow strict safety protocols, and participants receive close medical monitoring throughout the study. You can withdraw from a trial at any time without penalty.
Data updated March 1, 2026 from ClinicalTrials.gov
About This Data
Clinical trial information on this page is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health (NIH) and National Library of Medicine (NLM). Study data is refreshed every hour to ensure accuracy.
Medical Disclaimer: The information provided on this page is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider before making decisions about clinical trial participation or changes to your treatment plan.
Page reviewed by the HelloStudys Research Team · Last updated March 1, 2026 · Data from ClinicalTrials.gov